The following table provides an overview of the latest patents of Molecular Insight Pharmaceuticals, Inc. that has been opposed by its competitors. It provides an insight into the competitive landscape of the industry and highlights the patents that are subject to oppositions.

Patent NumberGrant DateTitleTotal Oppositions
EP3699162Jun 29, 2022Heterodimers Of Glutamic Acid1
EP3335736Dec 30, 2020Heterodimers Of Glutamic Acid3